Close
  • SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c
  • SENSEX Apr 25 2024 03:44
    74,339.44 +486.50 ( +0.66%)
  • NIFTY Apr 25 2024 03:39
    22,570.35 +167.95 ( +0.75%)
  • SENSEX Apr 25 2024 03:44
    74,339.44 +486.50 ( +0.66%)
  • NIFTY Apr 25 2024 03:39
    22,570.35 +167.95 ( +0.75%)
  • Nasdaq Apr 25 2024 04:30
    15,712.75 +16.11 ( +0.10%)
  • DJIA Apr 25 2024 04:30
    38,460.92 -42.77 (-0.11%)
  • S&P 500 Apr 25 2024 04:30
    5,071.63 +1.08 ( +0.02%)
  • Hang Seng Apr 25 2024 02:10
    17,284.54 +83.27 ( +0.48%)
  • Crude Oil Apr 25 2024 03:43
    6,903.00 +14.00 ( +0.20%)
  • Gold Apr 25 2024 03:44
    71,065.00 +15.00 ( +0.02%)
  • Silver Apr 25 2024 03:44
    80,700.00 +203.00 ( +0.25%)
  • Copper Apr 25 2024 03:21
    847.00 +3.90 ( +0.46%)
  • Pound / Rupee Dec 23 2016 22:30
    103.28 +0.27 ( +0.26%)
  • Dollar / Rupee Dec 23 2016 22:30
    83.31 -0.07 (-0.09%)
  • Euro / Rupee Dec 23 2016 22:30
    88.96 +0.13 ( +0.14%)
  • Yen / Rupee Dec 23 2016 22:30
    0.54 0.00 (-0.11%)

BSE Code : | NSE Symbol : | ISIN:| SECTOR : |

NSE BSE
 

Volume

Prev. Close

Open Price

Bid Price (QTY)

Offer Price (QTY)

 

Today’s High/Low -

52 wk High/Low -

Key Stats

MARKET CAP (RS CR) 9.49
P/E 17.15
BOOK VALUE (RS) 5.647817
DIV (%) 0
MARKET LOT 1
EPS (TTM) 1.15
PRICE/BOOK 3.49161454770932
DIV YIELD.(%) 0
FACE VALUE (RS) 10
DELIVERABLES (%)
4

News & Announcements

14-Feb-2024

C J Gelatine Products reports standalone net loss of Rs 0.29 crore in the December 2023 quarter

03-Feb-2024

C.J. Gelatine Products to conduct board meeting

30-Dec-2023

C J Gelatine Products Ltd - Closure of Trading Window

13-Nov-2023

C J Gelatine Products Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication

03-Feb-2024

C.J. Gelatine Products to conduct board meeting

07-Nov-2023

C.J. Gelatine Products to discuss results

18-Aug-2023

C.J. Gelatine Products to convene AGM

08-Aug-2023

C.J. Gelatine Products to hold board meeting

Corporate Actions

Bonus
Splits
Dividends
Rights
Capital Structure
Book Closure
Board Meeting
AGM
EGM
 

Financials

Income Statement

Standalone
Consolidated
 

Peers Comparsion

Select Company Name BSE Code NSE Symbol
Aarti Industries Ltd 524208 AARTIIND
Aarti Surfactants Ltd 543210 AARTISURF
Aarti Surfactants Ltd Partly Paidup 890180 AARTIPP
Absolute Aromatics Ltd 40209
Aditya Info-Soft Ltd 530693
Advance Petrochemicals Ltd 506947
Aether Industries Ltd 543534 AETHER
Alang Industrial Gases Ltd 531517
Alkali Metals Ltd 533029 ALKALI
Alkyl Amines Chemicals Ltd 506767 ALKYLAMINE
Allied Resins & Chemicals Ltd(merged) 524538 ALLIEDRES
Alufluoride Ltd 524634
Amal Ltd 506597
Ambani Organics Ltd 535097 AMBANIORG
Ambica Agarbathies Aroma & Industries Ltd 532335 AMBICAAGAR
Amex Carbonates & Chemicals Ltd 531321
Amines & Plasticizers Ltd 506248 AMNPLST
Aminex Chemicals Ltd (Wound-up) 524386
Amit Alcohol & Carbon Dioxide Ltd (Merged) 506904
Anan Drug & Chem Ltd 531999
Andhra Petrochemicals Ltd 500012 ANDHRAPET
Anjana Explosives Ltd 40329
Anupam Rasayan India Ltd 543275 ANURAS
Arabian Petroleum Ltd 77164 ARABIAN
Archean Chemical Industries Ltd 543657 ACI
Archit Organosys Ltd 524640
ARCL Organics Ltd 543993
Arvee Laboratories (India) Ltd 535050 ARVEE
Arvin Liquid Gases Ltd 523404
Asiatic Oxygen Ltd 40030
Atul Ltd 500027 ATUL
Avikem Resins Ltd 523784
B L Industries (India) Ltd 530637
Balaji Amines Ltd 530999 BALAMINES
Barium Chemcials Ltd 506275
Baroda Carbons Ltd 523527
BASF India Ltd 500042 BASF
Benzo Petro International Ltd 524737
Benzo Petrochemicals Ltd (Wound Up) 524196
Bhagawati Gas Ltd 500051 BAGWATIGAS
Bhagawati Oxygen Ltd 509449
Bhatia Colour Chem Ltd 543497
Bhuruka Gases Ltd 509728
Bhuvan Tripura Industries Ltd 524725
Binaca Synthetic Resins Ltd 514344
Borax Morarji Ltd(Merged) 506315
Burmah Petro Products Ltd 40310
Cabot India Ltd 506700 CABOTINDIA
Camlin Fine Sciences Ltd 532834 CAMLINFINE
Canvay Chemicals Ltd 531535
Caprolactam Chemicals Ltd 507486
Carbon & Chemicals India Ltd (Merged) 505813
Castrol India Ltd 500870 CASTROLIND
Cellulose Products of India Ltd 506345
Chembond Chemicals Ltd 530871 CHEMBOND
Chemcon Speciality Chemicals Ltd 543233 CHEMCON
Chemcrux Enterprises Ltd 540395
Chemfab Alkalis Ltd 541269 CHEMFAB
Chemiesynth (Vapi) Ltd 539230
Chemplast Sanmar Ltd 543336 CHEMPLASTS
Chimique Laboratories (India) Ltd 40300
Ciba India Ltd(merged) 532184 CIBASPEC
Cilson Organics Ltd 532147
Citric India Ltd 506370
Citurgia Biochemicals Ltd 506373 CITURGIBIO
Clariant (India) Ltd(merged) 500373 CLARIANT
Clarisis Organics Ltd 524806
Claro India Ltd 524366
Clean Science & Technology Ltd 543318 CLEAN
Cochin Minerals & Rutile Ltd 513353
Continental Petroleums Ltd 523232
Core Organics Ltd 524466
Crestchem Ltd 526269
Dai-ichi Karkaria Ltd 526821 DAICHIKARK
DDev Plastiks Industries Ltd 543547
Deccan Petroleums Ltd 526375
Deepak Fertilizers & Petrochemicals Corp Ltd 500645 DEEPAKFERT
Deepak Nitrite Ltd 506401 DEEPAKNTR
Diamines & Chemicals Ltd 500120 DIAMINESQ
DIC India Ltd 500089 DICIND
Diviya Chemicals Ltd 506810
DMCC Speciality Chemicals Ltd 506405 DMCC
Doctors Biotech India Ltd 512079
Dujodwala Paper Chemicals Ltd 524276
Eiko Lifesciences Ltd 540204
Eiko Lifesciences Ltd Partly Paidup 890189
Elantas Beck India Ltd 500123 DRBECK
Ellenbarrie Industrial Gases Ltd 590087
Emmessar Biotech & Nutrition Ltd 524768
EPIC Enzymes Pharma & Industrial Chemicals Ltd 524374
Fairchem Organics Ltd 543252 FAIRCHEMOR
Ficom Organics Ltd(merged) 506443 FICOMORGAN
Fine Organic Industries Ltd 541557 FINEORG
Fineotex Chemical Ltd 533333 FCL
Foseco India Ltd 500150 FOSECOIND
Futuristic Offshore Services and Chemical Ltd 500154 GANESHANHY
Gagan Gases Ltd 524624
Galaxy Oleo-Chem (India) Ltd 40207
Galaxy Surfactants Ltd 540935 GALAXYSURF
GBL Industries Ltd 539009
GHCL Ltd 500171 GHCL
Glory Chemicals Ltd 531532
GOCL Corporation Ltd 506480 GOCLCORP
Godrej Industries Ltd 500164 GODREJIND
Goiex Michio Sudo Ltd 507978
GOM Industries Ltd 523802
Goodearth Industries Ltd 526929
Goodearth Organic (India) Ltd [Wound-up] 524300
Govind Poy Oxygen Ltd 509586
GP Petroleums Ltd 532543 GULFPETRO
Grauer & Weil (India) Ltd 505710 GRAUWEIL
Gresoil (India) Ltd 530483
Gujarat Carbon & Industries Ltd 506457
Gujarat Fluorochemicals Ltd 542812 FLUOROCHEM
Gujarat Indo-Lube Ltd 523552
Gujarat Narmada Valley Fertilizers & Chemicals Ltd 500670 GNFC
Gujarat Oiland Industries Ltd (Wound Up) 507866
Gujarat Organics Ltd 501368
Gujarat Speciality Lubes Ltd 523880
Gulf Oil India Ltd - Merged 511026 GULFOIL
Gulf Oil Lubricants India Ltd 538567 GULFOILLUB
Gulshan Sugars & Chemicals Ltd(merged) 524184
Haryana Leather Chemicals Ltd 524080
Hemo Organic Ltd 524590
Hico Products Ltd 506461
Hi-Green Carbon Ltd 91663 HIGREEN
Hilltone Industrial Gases Ltd 40441
Himadri Speciality Chemical Ltd 500184 HSCL
Hindcon Chemicals Ltd 535053 HINDCON
Hindustan Industrial Chemicals Ltd 524679 HINDINDCHM
Hindustan Organic Chemicals Ltd 500449 HOCL
Hindustan Oxygen Gas Ltd 509660
HP Adhesives Ltd 543433 HPAL
Hubergroup India Pvt Ltd 523886 MICRO
I G Petrochemicals Ltd 500199 IGPL
IBP Co. Ltd(merged) 500198 IBP
Iccon Oil & Specialities Ltd 523766
India Carbon Ltd 40012
India Gelatine & Chemicals Ltd 531253
Indian Electro Chemicals Ltd 506490
Indo Amines Ltd 524648 INDOAMIN
Indo Borax & Chemicals Ltd 524342 INDOBORAX
Indo Gulf Industries Ltd 506945
Indo Vanillon Chemicals Ltd 531267
Indu Nissan Oxo Chemicals Industries Ltd 500208 INDUNISSAN
Inox Air Products Pvt Ltd 526534 INDOXYGEN
Insilco Ltd 500211 INSILCO
Iota Chemiculture Ltd(Liquidated) 524630
IVP Ltd 507580 IVP
J F Laboratories Ltd 523804 JFLABS
J.G.Chemicals Ltd 544138 JGCHEM
J.R. Organics Ltd 506650
Jay Agrochem Ltd (Wound Up) 513504
Jayant Agro Organics Ltd 524330 JAYAGROGN
Jocil Ltd 500561 JOCIL
Jubilant Industries Ltd 533320 JUBLINDS
Jubilant Ingrevia Ltd 543271 JUBLINGREA
Jyoti Resins and Adhesives Ltd 514448
K P Gelatines & Chemicals India Ltd (Wound-up) 524741
Kamar Chemicals & Industries Ltd 531001
Kanchi Karpooram Ltd 538896
Kanoria Chemicals & Industries Ltd 506525 KANORICHEM
Kanva Hydro Chem Ltd 524685
Karnataka Chemical Industries Corp Ltd 530105
Karnav Leather Chemicals Ltd 524432
Keltech Energies Ltd 506528
Kesar Petroproducts Ltd 524174
Kilburn Chemicals Ltd 524699
Kings India Chemicals Corporation Ltd 524214
Kothari Polymers Ltd 40360
Krishna Plastochem Ltd (Wound Up) 524254
Laxmi Organic Industries Ltd 543277 LXCHEM
Lime Chemicals Ltd 507759
Linde India Ltd 523457 LINDEINDIA
Link Pharma Chem Ltd 524748
Lords Chemicals Ltd 530039
M.P. Carbide & Chemicals Ltd 506925
Madras Petrochem Ltd 500261
Maha Chemicals Ltd (Wound-up) 524556
Maharashtra Explosives Ltd (Wound-up) 506871
Maharashtra Polybutenes Ltd 524232
Mangalam Organics Ltd 514418 MANORG
Mark Omega Organic Industries Ltd 524681
Maruti Industrial Carbohydrates Ltd 524814
Maruti Organics Ltd 524402 MARUTIORNG
Master Chemicals Ltd 506867
Mehta Rubber Chemcials Ltd 526536
Mehta Sulfites (India) Ltd 530029
mk Aromatics Ltd 531011
Motorol (I) Ltd 508965 MOTOROL
Motorol Enterprises Ltd 523049 RINKIPETRO
Motorol Speciality Oils Ltd 506954
MTZ Industries Ltd 500275 METAZINC
Murablack India Ltd 523578 MURABLACK
Nacro Chemicals Ltd 524350
Nariman Point Chemical Industries Ltd 524224
Narmada Gelatines Ltd 526739 SHAWGELTIN
National Oxygen Ltd 507813 NOL
Navin Fluorine International Ltd 532504 NAVINFLUOR
Neogen Chemicals Ltd 542665 NEOGEN
Newton Engineering & Chemicals Ltd 524474
Nikhil Adhesives Ltd 526159
Niraj Petrochemicals Ltd 500454 NIRAJPETRO
Nitta Gelatin India Ltd 506532 KERALACHEM
NLC Nalco India Ltd 524101 NALCOCHEM
Noble Explochem Ltd 506991
NOCIL Ltd 500730 NOCIL
Nouryon Chemical India Pvt Ltd 500082 CENTAKCHEM
Nova Chemie (India) Ltd 40188
Ojas Technochem Products Ltd(wound-up) 526427
Omkar Speciality Chemicals Ltd 533317 OMKARCHEM
Organic Coatings Ltd 531157
Orient Organics Ltd 524766
Oriental Aromatics Ltd 500078 OAL
Oriental Carbon & Chemicals Ltd 506579 OCCL
Orissaa Organics Ltd 524392
Oswali Chemicals Ltd 506916
Padmanabh Industries Ltd 526905
Paintex Chemicals (Bombay) Ltd 524178
Paragon Fine and Speciality Chemical Ltd 91901 PARAGON
Paschim Petrochem Ltd 531005
Paushak Ltd 532742
PCBL Ltd 506590 PCBL
Pentasia Chemicals Ltd (Merged) 507739
Pidilite Industries Ltd 500331 PIDILITIND
Pinky Chemicals Ltd 524671
Plastiblends India Ltd 523648 PLASTIBLEN
Platinum Industries Ltd 544134 PLATIND
Polyolefins Industries Ltd (Merged) 506610
Premier Explosives Ltd 526247 PREMEXPLN
Privi Speciality Chemicals Ltd 530117 PRIVISCL
Protchem Industries (India) Ltd 524117
Rain Calcining Ltd(merged) 532153 RAINCALCIN
Rathi India Ltd 506959
Refnol Resins & Chemicals Ltd(Merged) 530815
Rencal Chemicals (India) Ltd 524510
Resonance Specialities Ltd 524218
Revati Organics Ltd 524504
Rhodia Specialty Chemicals India Ltd(Merged) 506230 ALBRMORARJ
Rite Zone Chemcon India Ltd 535489 RITEZONE
Ritesh International Ltd 519097
Rock Hard Petro Chemical Industries Ltd 524194
Rossari Biotech Ltd 543213 ROSSARI
Rukmani Metals & Gaseous Ltd 40695
S H Kelkar & Company Ltd 539450 SHK
S K R Chemicals Ltd 530371
Sadhana Nitro Chem Ltd 506642 SADHNANIQ
Salvigor Laboratories Ltd (Merged) 524268
Sanderson Industries Ltd 507728 SANDERIND
Sanginita Chemicals Ltd 538408 SANGINITA
Sarang Chemicals Ltd 532031
Searsole Chemicals Ltd (Wound-up) 506644
Seya Industries Ltd 524324 SEYAIND
Shaper Chemicals Ltd (Wound-up) 524566
Shayona Petrochem Ltd 531538
Shentracon Chemicals Ltd 530757
Shree Benzophen Industries Ltd 531389
Shree Neelachal Laboratories Ltd 531487
Shri Ambuja Petro Chemicals Ltd 506742
Shri Aster Silicates Ltd 533219 SHRIASTER
Shri Nicosect Ltd 526437
SI Group - India Ltd 506460 SIGROUPIND
SMZS Chemicals Ltd(wound-up) 524160 SMZSCHEM
Solar Industries India Ltd 532725 SOLARINDS
Sonal Sil Chem Ltd 524673
Southern Gas Ltd 509910
Speciality Petrolubes Ltd 523525
Sree Rayalaseema Hi-Strength Hypo Ltd 532842 SRHHYPOLTD
Sree Rayalaseema Petrochemicals Ltd (Merged) 524618
Sreechem Resins Ltd 514248
SRF Ltd 503806 SRF
SRHHL Industries Ltd (Merged) 524410 SRHHLINDST
Sterling Biotech Ltd 512299 STERLINBIO
Sudev Chemicals Ltd 40666
Sun Star Chemicals Ltd 524536 SUNSTRCHEM
Sunshield Chemicals Ltd 530845
Sunstar Lubricants Ltd 524452 SUNSTARLUB
Superior Air Products Ltd (Merged) 526469
Swarnajyothi Agrotech & Power Ltd 590090
Tamil Nadu Industrial Explosives Ltd 524028
Tamil Nadu Petro Products Ltd 500777 TNPETRO
Tanfac Industries Ltd 506854 TANFACIND
Tata Chemicals Ltd 500770 TATACHEM
Tatva Chintan Pharma Chem Ltd 543321 TATVA
TECIL Chemical & Hydro Power Ltd 506680 TECILCHEM
Tetrahedron Ltd 40308
Thirani Chemicals Ltd (Merged) 524125
Thirumalai Chemicals Ltd 500412 TIRUMALCHM
Tide Water Oil Co (I) Ltd 590005 TIDEWATER
Tirupati Inks Ltd 533258
Transpek Industry Ltd 506687 TRANSPEK
Tria Fine Chem Ltd 524721
Tribology India Ltd 40171
Trigon Zinco Ltd 530287
Tulasee Bio-Ethanol Ltd 524514
U P Lime Chem Ltd 524677
Unique Oils India Ltd 523250
Urvi Chemicals & Allied Industries Ltd 501371
Vadilal Chemicals Ltd 40485
Vadivarhe Speciality Chemicals Ltd 538429 VSCL
Valiant Organics Ltd 540145 VALIANTORG
VBC Industries Ltd 524310
Vibros Organics Ltd 530487
Vijayshree Chemicals (India) Ltd 524312
Vikas Wsp Ltd 519307 VIKASWSP
Vinati Organics Ltd 524200 VINATIORGA
Vishnu Chemicals Ltd 516072 VISHNU
Vision Organics Ltd 532383 VISIONLTD
Vital Chemtech Ltd 535490 VITAL
Yasho Industries Ltd 541167 YASHO
Yug Decor Ltd 540550

Share Holding

Category No. of shares Percentage
Total Foreign 61945 1.29
Total Institutions 300 0.01
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 29268 0.61
Total Promoters 2953928 61.37
Total Public & others 1767859 36.73
Total 4813300 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

About C J Gelatine Products Ltd

C J Gelatine Products Limited was incorporated in 1983 and started its production in 1984 with technical assistance from G.T. Gelatine Technology of the United Kingdom. Within a year from the initial production of Gelatine, it scaled to new heights with quality production. The Company is the leading producers of premium Gelatine meeting the global quality standards. It is involved in manufacture of Gelatin and Di Calcium Phosphate (DCP) at Raisen in Madhya Pradesh. Apart from this, Gelatin represents an omnipresent element in foods, drugs, and supplements used as a thickener, plasticizer, emulsifier, foaming agent, moisture retainer, texture enhancer, and binding agent. As a rich source of protein, the Company finds application in numerous end-use sectors including pharmaceuticals, food and beverage, photographic supplies, cosmetics, explosives, electroplating, dyes, papermaking and printing, among others. Rising standards of living, easier access to healthcare services, increase in disposable incomes and rapidly aging world population represent key factors driving growth in demand for Gelatin. Improving lifestyles in developing economies of India and China have promoted market expansion. Lack of availability of competitive substitutes in the market has made the Company one of the most indispensable feedstock in various end-use industries. The Company offer a unique combination of Neutral taste, Easy Digestibility, Brilliant clarity and reversible settling capacity. It consist of almost all 18 amino acids essential for human nutrition. The use of Gelatin in manufacture of various pharmaceutical dosage forms dates back to the early 19th century and possibly earlier. Today, the commonly recognized dosage forms using Gelatin are two - piece hard capsules, soft elastic gelatin capsules (Sofftgels), tableting, tablet coating, granulation, encapsulation and micro - encapsulation??. Di-Calcium Phosphate is a high purity natural mineral supplement for poultry feeds. As it is derived from bovine bones of healthy animals, it (DCP) is of excellent digestibility and solubility. It allows chemical substances to penetrate sufficient into the emulsion, and in similar way it allows these solutions to be washed away after developing. The calcium phosphates, carbonates & other minerals attached with bones dissolve in the acid to form Monocalcium phosphate leaving behind the organic collagen in the residual bone. This monocalcium phosphate liquid is precipitated by calcium hydroxide to produce Dicalcium Phosphate (DCP) as its byproduct which is a main constituent for the cattle & poultry feed. The treated residual bones are now known as Ossein. The limed soaked ossein are then washed with water to remove lime completely & then treated with dilute solution of weak acid to maintain pH in the range 5 - 6. Ossein after acid treatment is taken for Gelatin extraction.

C J Gelatine Products Ltd Chairman Speech

Dear Shareholders,

The Company has achieved its highest turnover of all times with moderate performance during the financial year 2020-21 despite the global COVID-19 pandemic. The Company has been working diligently on many strategic initiatives including cost efficiency projects, continuous improvement, utilization of installed capacity of Production etc.

Through our constant development efforts backed with our strong focus on current and emerging customer requirements, we will build our market presence and strive to enhance our value proposition to our customers.

The Management and the Board of Directors have been looking at various options to help steer the Company to a path of profitability and growth in the future and I am confident that the Company will be able to sustain its performance with the perseverant efforts of the Management under the guidance of the Board. The Company’s products are a critical input for the Pharmaceutical Industry which continues to remain robust.

   

C J Gelatine Products Ltd Company History

C J Gelatine Products Limited was incorporated in 1983 and started its production in 1984 with technical assistance from G.T. Gelatine Technology of the United Kingdom. Within a year from the initial production of Gelatine, it scaled to new heights with quality production. The Company is the leading producers of premium Gelatine meeting the global quality standards. It is involved in manufacture of Gelatin and Di Calcium Phosphate (DCP) at Raisen in Madhya Pradesh. Apart from this, Gelatin represents an omnipresent element in foods, drugs, and supplements used as a thickener, plasticizer, emulsifier, foaming agent, moisture retainer, texture enhancer, and binding agent. As a rich source of protein, the Company finds application in numerous end-use sectors including pharmaceuticals, food and beverage, photographic supplies, cosmetics, explosives, electroplating, dyes, papermaking and printing, among others. Rising standards of living, easier access to healthcare services, increase in disposable incomes and rapidly aging world population represent key factors driving growth in demand for Gelatin. Improving lifestyles in developing economies of India and China have promoted market expansion. Lack of availability of competitive substitutes in the market has made the Company one of the most indispensable feedstock in various end-use industries. The Company offer a unique combination of Neutral taste, Easy Digestibility, Brilliant clarity and reversible settling capacity. It consist of almost all 18 amino acids essential for human nutrition. The use of Gelatin in manufacture of various pharmaceutical dosage forms dates back to the early 19th century and possibly earlier. Today, the commonly recognized dosage forms using Gelatin are two - piece hard capsules, soft elastic gelatin capsules (Sofftgels), tableting, tablet coating, granulation, encapsulation and micro - encapsulation??. Di-Calcium Phosphate is a high purity natural mineral supplement for poultry feeds. As it is derived from bovine bones of healthy animals, it (DCP) is of excellent digestibility and solubility. It allows chemical substances to penetrate sufficient into the emulsion, and in similar way it allows these solutions to be washed away after developing. The calcium phosphates, carbonates & other minerals attached with bones dissolve in the acid to form Monocalcium phosphate leaving behind the organic collagen in the residual bone. This monocalcium phosphate liquid is precipitated by calcium hydroxide to produce Dicalcium Phosphate (DCP) as its byproduct which is a main constituent for the cattle & poultry feed. The treated residual bones are now known as Ossein. The limed soaked ossein are then washed with water to remove lime completely & then treated with dilute solution of weak acid to maintain pH in the range 5 - 6. Ossein after acid treatment is taken for Gelatin extraction.

C J Gelatine Products Ltd Directors Reports

To,

The Members of C.J.Gelatine Products Limited (CIN: L24295MH1980PLC023206)

Your directors have pleasure in presenting the 43rd Annual Report and Audited Financial Statements of your Company for the year ended March 31, 2023.

Financial Highlights (Rs. in Lakhs except EPS)

Particulars

For the year ended March 31, 2023 For the year ended March 31, 2022

Revenue From Operation (Net)

3680.38 3967.23

Other Income

59.35 4.19

Total Revenue/ Income

3739.73 3971.43

Profit/ (Loss) before Exceptional & Extraordinary Items and tax

31.87 40.74

Exceptional Items

-- --

Extraordinary Items

-- --

Prior Period Items

-- --

Profit/ (Loss) before tax

31.87 40.74

Current Tax Expenses for Current Year

10.52 6.36

Deferred Tax Assets / (Liability)

(1.59) (0.31)

Profit / (Loss) After Tax

22.93 34.69

Earning Per Shares (EPS)

0.48

0.72

Basic

Diluted

0.48 0.72

1 STATE OF COMPANY'S AFFAIRS:

During the financial year under review, the total Income (including other income) of the Company was Rs. 3739.73/- Lakh against Rs. 3971.43/- Lakhs in the previous year. The Company has earned a Profit (After Tax) of Rs. 22.93/- Lakhs as compared to Profit (After Tax) of Rs. 34.69/- Lakhs in the previous year.

Your directors are continuously looking for avenues for future growth of the Company.

2. DIVIDEND:

Your directors do not recommend any dividend for the financial year ended March 31, 2023.

3. TRANSFER TO RESERVES IN TERMS OF SECTION 134(3)0) OF THE COMPANIES ACT, 2013:

For the financial year ended March 31, 2023, the Company has transferred Rs. 22.93/- Lakhs to Surplus Balance in Statement of Profit and Loss under Reserves and Surplus head.

4. MATERIAL CHANGES BETWEEN THE END OF FINANCIAL YEAR AND DATE OF THE BOARDS' REPORT:

No material changes and commitments affecting the financial position of the Company occurred between the end of the financial year to which these financial statements relate and on the date of this report.

5. CHANGE IN THE NATURE OF BUSINESS:

There is no change in the nature of the business of the Company during the year.

6. MEMORANDUM OF ASSOCIATION:

During the year under review the Company at 42nd Annual General Meeting held on September 24, 2022 has adopted new set of the Memorandum of Association of the Company under provisions of the Companies Act, 2013 and Rules made thereunder.

7. WEB ADDRESS, IF ANY, WHERE ANNUAL RETURN U/S 92(3) HAS BEEN PLACED:

In accordance with the provisions of Companies (Amendment) Act, 2017, read with Section 134(3) of the Companies Act, 2013, the copy of Annual Return under section 92(3) is hosted on the Company's website viz. www.cjgelatineproducts.com

8. MEETINGS OF THE BOARD OF DIRECTORS:

During the year ended March 31, 2023, Five (05) Board Meetings were held on 28/05/2022, 06/08/2022, 12/11/2022, 11/02/2023 and 18/03/2023.

9. DETAILS OF SUBSIDIARY/ JOINT VENTURES/ ASSOCIATE COMPANIES:

As on March 31, 2023, the Company does not have any Subsidiary / Joint Venture / Associate Companies.

Further no Company has become or ceased to be Subsidiaries, Joint Ventures or Associate Company, during the financial year under review.

10. PERFORMANCE OF SUBSIDIARY/ ASSOCIATES/ JOINT VENTURE COMPANIES: Not applicable 11 DIRECTORS:

(A) Changes in Directors, Key Managerial Personnel and Senior Management:

During the financial year under review, following changes have occurred in the Constitution / Composition of the Board of Directors:

? Changed the Occupation Category of Mrs. Jasneet Kaur (DIN: 06995139), from Professional/Executive to Promoter/Executive director of the Company at the 42nd Annual General Meeting of the Company held on September 24, 2022.

? Mr. Vikas Jain (M. No.: A50716) was appointed as a Company Secretary of the Company with effect from May 28, 2022 and resigned with effect from the closure of the business hours of February 28, 2023 due to personal reason.

? Mr. Mayank Lashkari (M. No.: A34448) has been appointed as a Company Secretary of the Company with effect from March 18, 2023.

? There is no change in senior management.

Further, Mr. Vikas Gupta (DIN: 03603519), Mr. Sandeep Singh (DIN: 03603531) and Mr. Amarjot Singh (DIN: 07115513) Independent Directors of the Company who were appointed at 39th Annual General Meeting of the Company duly held on September 30, 2019 for second term of five years upto March 31, 2024 and due to such completion of their tenure, it is being required to appoint any other person(s) at their place on account of vacation of office.

Pursuant to provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company requires approval of Shareholders for appointment / reappointment of a person on the Board of Directors within three months from the date of such appointment / reappointment. Hence, based on recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company proposes the appointment of the following person(s) as Independent Directors of the Company for a term of five consecutive years w.e.f. date of 43rd Annual General Meeting:

1. Mr. Harish Pande (DIN 01575625);

2. Mr. Satish Chander Mathur (DIN 02847887); and

3. Mr. Rajesh Divetia (DIN 10253214).

The necessary details / disclosure of the proposed appointments is part of Notice of the 43rd Annual General meeting read with Explanatory Statement enclosed with the said Notice.

Further, Mr. Harman Singh (DIN: 01406962), Executive Director of the Company, is being retired by rotation at the 43rd Annual General Meeting and being eligible offer himself for reappointment.

The Board of Directors recommends the aforesaid appointment / re-appointment.

(B) Declaration by Independent Directors:

All the Independent Directors have submitted to the company, declarations to the effect that they meet the criteria of Independence as specified/provided in Section 149 of the Companies Act, 2013 and Regulation 16 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Further in terms of the Regulation 25(8) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; they have confirmed that they are not aware of any circumstances or situation which exists or may be reasonably anticipated that could impair or impact their ability to discharge their duties with an objective independent judgment and without any external influence.

A separate meeting of Independent Directors of the Company was conducted on March 2, 2023 in terms of provisions of Schedule IV of the Companies Act, 2013. All the independent directors of the Company except Mr. Amarjot Singh (DIN: 07115513) were present at the meeting.

(C) Opinion of the Board with regard to integrity, expertise and experience of the Independent Director appointed during the year: NA

During the year under review, Company has not appointed any Independent Directors.

Further, the persons propose to be appointed as Independent Directors of the Company holds the requisite integrity, expertise and experience in the specific area. The details are given in the explanatory statement enclosed with the Notice of 43rd Annual General Meeting.

(D) Formal Annual Evaluation:

Pursuant to the provisions of section 134 (3)(P) of the Companies Act, 2013 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board adopted a formal mechanism for evaluating its performance and as well as that of its Committees and Individual Directors, including the Chairman of the Board. The exercise was carried out through a structured evaluation process covering various aspects of the Boards functioning such as composition of the Board & committees, experience & competencies, performance of specific duties & obligations, governance issues etc.

The evaluation of the Independent Directors was carried out by the entire Board and that of the Chairman and Non-Independent Directors were carried out by the Independent Directors.

The Directors were satisfied with the evaluation results, which reflected the overall engagement and effectiveness of the Board and its Committees with the Company.

12. AUDITORS:

(A) Statutory Auditors:

In terms of the provisions of Section 139 of the Companies Act, 2013, Members of the Company in the 39th Annual General Meeting (AGM) held on 30th September, 2019 have appointed M/s S P A R K & Associates, Chartered Accountants LLP (FRN: 005313C/C400311) erstwhile M/s S P A R K & Associates (FRN: 005313-C400311), as the Statutory Auditors of the Company for a period of Five years i.e. up to the conclusion of the 44th Annual General Meeting of the Company to be held in the financial year 2024-2025.

There are no qualifications or adverse remarks in the Auditors' Report for the financial year ended March 31, 2023, which require any clarification/explanation.

The notes on financial statements are self-explanatory and needs no further explanation.

Further the Auditors' Report for the financial year ended, March 31, 2023 is annexed herewith for your kind perusal and information.

(B) Secretarial Auditors:

Pursuant to the provisions of Section 204 of the Companies Act, 2013 and Rules made thereunder, the Company has appointed M/s M M Chawla & Associates, Company Secretary in Practice (FCS 67, CP 716), to undertake the secretarial audit of the Company. Secretarial Audit Report for the financial year 2022-23 in the prescribed Form MR-3 is attached as Annexure-I to this report.

There are no qualifications or adverse remarks in the Secretarial Audit Report for the financial year ended March 31, 2023, which require no clarification/explanation.

(C) Cost Auditors:

During the reporting period, the provisions of the Cost Audit / Cost Audit Report are not applicable to the Company.

13. ANNUAL SECRETARIAL COMPLIANCE REPORT:

Pursuant to Regulation 24A of the Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Annual Secretarial Compliance Report for the financial year 2022-23 issued by M/s M M Chawla & Associates, Company Secretary in Practice (FCS 67, CP 716) is attached as Annexure-II to this report.

14. LOANS, GUARANTEES AND INVESTMENTS:

The Company has not given any loan to any person or other body corporate, or given any guarantee or provided security in connection with a loan to any other body corporate or person, or acquired by way of subscription, purchase or otherwise, the securities of any other body corporate, during the financial year under review.

15. RELATED PARTY TRANSACTIONS:

During the financial year under review, the Company has not entered into any contracts / arrangements / transactions with its related parties under Section 188(1) of the Companies Act 2013.

16. CORPORATE SOCIAL RESPONSIBILITY (CSR):

During the reporting period, the provisions of the CSR are not applicable to the Company.

17. CONSERVATION OF ENERGY:

In terms of Section 134(3)(m) of the Companies Act, 2013 and the rules made there under, relevant information about Conservation of Energy are as follows:

(i) The steps taken or impact on conservation of energy:

• Installation of new energy efficient chilling equipment.

• Replaced old pumps with energy efficient new pumps.

• Regular and Halogen lights are being replaced phase-wise in selective areas by LED lights for energy saving.

On implementation of the above, the Company expects to substantially benefit in saving power and water consumption at various stages of the production cycle.

(ii) the steps taken by the Company for utilizing alternate sources of energy:

• Study on use of other alternate fuel for boiler in order to reduce energy cost.

• Replacement of existing air compressors with few new energy efficient air compressors.

• Studying feasibility of PPA for solar/ hybrid energy for electricity generation.

• Studying feasibility of using ancillary equipment that could help in reducing cost of chemicals, electricity saving and downtime of pivitol utility equipment.

(iii) the capital investment on energy conservation equipments: The Company has spent an amount of Rs. 16.84 Lakhs as capital expenditure on energy saving equipment during the year 2022-23.

18. TECHNOLOGY ABSORPTION:

In terms of Section 134(3)(m) of the Companies Act, 2013 and the rules made there under, relevant information about Technology Absorption are as follows:

(i) the efforts made towards technology absorption & the benefits derived like product improvement, cost reduction, product development or import substitution: NA

As the company's products are manufactured by using in-house know how and no outside technology is being used for manufacturing activities. Therefore, no technology absorption is required. The Company constantly strives for maintenance and improvement in quality of its products and entire Research & Development activities are directed to achieve the aforesaid goal.

(ii) in case of imported technology (imported during the last three years reckoned from the beginning of the financial year)-

(a) the details of technology imported: Nil

(b) the year of import: Nil

(c) whether the technology been fully absorbed: Nil

(d) if not fully absorbed, areas where absorption has not taken place, and the reasons thereof: Nil

(iii) the expenditure incurred on Research and Development: Nil

19. FOREIGN EXCHANGE EARNINGS AND OUTGO:

In terms of Section 134(3)(m) of the Companies Act, 2013 and the rules made there under, relevant information about Foreign Exchange Earnings and Outgo are as follows:

(i) The Foreign Exchange earned in terms of actual inflows during the year: Nil

(ii) The Foreign Exchange outgo during the year in terms of actual outflows: Nil

20. RISK MANAGEMENT:

The Board of Directors and Management of the Company has evaluated the various risks faced by the Company and suggests steps to be taken to control and mitigate the same through a properly defined framework to sustain the operations of the Company for the foreseeable future.

? Some of the key risk areas identified for mitigation and corrective action include:

• Crushed Bone availability and pricing patterns;

• Impact of the high cost of Crushed Bone on the cost of production;

• Water scarcity for operational requirements;

• Coal Prices & Availability; and

• Energy Charges.

21 INTERNAL FINANCIAL CONTROLS WITH REFERENCE TO THE FINANCIAL STATEMENTS:

The Company has in place adequate Internal Financial Controls with reference to financial statements.

22. DETAILS OF FRAUDS REPORTABLE U/S 143(12):

During the financial year under review, there is no fraud being or has been committed in the Company or against the Company by officers or employees of the Company, which are reportable by the Auditors to the Central

Government or to the Board or to the Audit Committee under Section 143(12) of the Companies Act, 2013; Therefore, no disclosure required in this regard.

23. DEPOSITS:

Your directors state that no disclosure or reporting is required in respect of details relating to deposits covered under Chapter V of the Act, because there were no transactions on these items during the financial year under review.

24. DETAILS OF MONEY/UNSECURED LOAN ACCEPTED UNDER RULE 2(1)(C).

During the financial year under review, the Company has accepted unsecured loan from the Managing Director of the Company and there is an outstanding balance of Rs. 4,67,00,000/- (Rupees Four Crore and Sixty-Seven Lakh only) as on March 31, 2023.

25. GENERAL DISCLOSURES:

Your directors state that no disclosure or reporting is required in respect of the following items as there were no transactions on these items during the year under review:

1. Issue of Bonus Shares and/or Right Shares.

2. Issue of equity shares with differential rights as to dividend, voting or otherwise.

3. Issue of Sweat Equity Shares.

4. Issue of shares through/ under the Employee Stock Option Scheme.

5. Detailed reasons for revision of financial statement or Board's Report.

6. Buy Back of Shares.

26. SIGNIFICANT OR MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS WHICH IMPACT THE GOING CONCERN STATUS AND COMPANY'S OPERATIONS IN FUTURE:

During the financial year under review, no significant or material orders passed by the Regulators or Courts or Tribunals which impact the going concern status and Company's operations in future.

27. DIRECTORS RESPONSIBILITY STATEMENT:

Pursuant to Section 134(3)(c) and 134(5) of the Companies Act, 2013 the Directors confirm that:

(a) in the preparation of the annual accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures;

(b) the directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the financial year and of the profit and loss of the company for that period;

(c) the directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities;

(d) the directors had prepared the annual accounts on a going concern basis; and

(e) the directors, had laid down internal financial controls to be followed by the company and that such internal financial controls are adequate and were operating effectively.

(f) the directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.

28. COMPLIANCES OF SECRETARIAL STANDARDS:

The Directors have devised proper systems to ensure compliance with the provisions of all applicable Secretarial Standards and that such systems are adequate and operating effectively.

29. MAINTENANCE OF COST RECORD U/S 148(1) OF THE COMPANIES ACT 2013:

During the reporting period the provisions with respect to Cost Audit or Cost Records is not applicable on the Company.

30. COMPLIANCE WITH PROVISIONS RELATING TO THE CONSTITUTION OF INTERNAL COMPLAINTS COMMITTEE

The Company has complied with the provision relating to the constitution/ re-constitution of Internal Complaints Committee under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013.

Further during the financial year under review, there were no cases filed under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013.

31 VIGIL MECHANISM:

As per provisions of Section 177(9) and Section 177(10) of the Companies Act, 2013 and Rules made thereunder, the Company has established a Vigil Mechanism for Directors and Employees to report their genuine concerns/ grievances, and said mechanism is overseen by the Audit Committee of the Company and the Company has also made provisions for direct access to the Chairman of the Audit Committee in appropriate or exceptional cases.

32. COMMITTEES OF THE BOARD:

The Company has constituted various Committees of the Board as required under the Companies Act, 2013 and the Listing Regulations. For details namely composition, number of meetings held, attendance of members, etc. of such Committees, please refer to the Corporate Governance Report which forms a part of this Annual Report.

33. COMPANY'S POLICY ON DIRECTORS' APPOINTMENT AND REMUNERATION INCLUDING CRITERIA FOR DETERMINING QUALIFICATIONS, POSITIVE ATTRIBUTES, INDEPENDENCE OF A DIRECTOR AND OTHER MATTERS PROVIDED UNDER SUB-SECTION (3) OF SECTION 178 & REMUNERATION POLICY:

Policy on Directors' appointment is to follow the criteria as laid down under the Companies Act, 2013, the Listing Agreement with Stock Exchanges and good corporate practices. Emphasis is given to persons from diverse fields or professions.

The policy of the Company on Directors' appointment and remuneration, including the criteria for determining the qualifications, positive attributes, independence of a Director and other matters, as required under Section 178(3) of Companies Act, 2013 is available on our website i.e. www.cjgelatineproducts.com.

34. DISCLOSURE ON RECEIVING OF REMUNERATION OR COMMISSION FROM ANY HOLDING OR SUBSIDIARY COMPANY: Not applicable.

35. DISCLOSURE PURSUANT TO SECTION 197 READ WITH RULE 5(1) OF THE COMPANIES (APPOINTMENT AND REMUNERATION OF MANAGERIAL PERSONNEL) RULES, 2014:

The information required under Section 197 of the Act read with rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 are given below:

(i) The ratio of the remuneration of each director to the median remuneration of the employees of the Company for the financial year:

Sr. Name & Designation of Directors No.

Remuneration Paid during the

Financial year 2022-23

Ratio of the remuneration of each director to the median remuneration of the employees

1. Mr. Jaspal Singh-Managing Director

Rs. 24,00,000/- 9.36:1

2. Mr. Harman Singh-Director & Chief Financial Officer

Rs.6,09,000/- 2.38:1

3. Mrs. Jasneet Kaur-Director

Rs. 4,50,000/- 1.76:1

(Note: Median Remuneration of the Employee is Rs. 2,56,352/-)

(ii) The percentage increase in remuneration of each director, Chief Financial Officer, Chief Executive Officer, Company Secretary or Manager if any, in the financial year:

> There were no increase in the remuneration of Mr. Jaspal Singh (DIN: 01406945), Managing Director.

> Remuneration of Mrs. Jasneet Kaur (DIN: 06995139), Director of the Company has been increased to 50.00%.

> Remuneration of Mr. Harman Singh (DIN: 01406962), Director and Chief Financial Officer of the Company has been increased to 16.27%.

(iii) The percentage increase in the median remuneration of employees in the financial year: 7.13%

(iv) The number of permanent employees on the rolls of Company (As on 31-03-2023): 95

(v) Average percentile increases already made in the salaries of employees other than the managerial

personnel in the last financial year and its comparison with the percentile increase in the managerial

remuneration and justification thereof and point out if there are any exceptional circumstances for

increase in the managerial remuneration. (Rs. in Lakhs)

Remuneration paid to employees excluding managerial personnel for the FY 2021-22

Remuneration paid to employees excluding managerial personnel for the FY 2022-23 % change in remuneration paid to employees excluding managerial personnel Remuneration paid to managerial personnel for the FY 2021-22 Remuneration paid to managerial personnel for the FY 2022-23 % change in remuneration paid to managerial personnel

227.50

232.27 2.10% 35.96 39.04 8.57%

(vi) The Company affirms that the remuneration is as per the remuneration policy of the Company.

36. PARTICULARS OF EMPLOYEES PURSUANT TO SECTION 197 READ WITH RULE 5(2) OF THE COMPANIES (APPOINTMENT AND REMUNERATION OF MANAGERIAL PERSONNEL) RULES, 2014:

List of top ten employees in terms of remuneration drawn is attached as Annexure-III to this report.

There was no employee who in terms of remuneration drawn:

i. if employed throughout the financial year, was in receipt of remuneration for that year which, in the aggregate, was not more than one crore and two lakh rupees;

ii. if employed for a part of the financial year, was in receipt of remuneration for any part of that year, at a rate which, in the aggregate, was not more than eight lakh and fifty thousand rupees per month;

iii. if employed throughout the financial year or part thereof, was in receipt of remuneration in that year which, in the aggregate, or as the case may be, at a rate which, in the aggregate, is in excess of that drawn by the managing director or whole-time director or manager and holds by himself or along with his spouse and dependent children, not more than two percent of the equity shares of the company.

37. LISTING OF EQUITY SHARES and LISTING FEES:

The Company's shares are listed at BSE Limited (Formerly Bombay Stock Exchange), which provides a wider access to the investors nationwide.

The Company has paid the annual listing fees up to March 31, 2024 to the BSE Ltd and Annual Custody / Issuer Fees to National Securities Depository Limited and Central Depository Services (India) Limited upto March 31, 2024.

38. SHARES IN SUSPENSE ACCOUNT AND UNCLAIMED SUSPENSE ACCOUNT:

As on March 31, 2023, there are 160 equity shares which are lying into Unclaimed Suspense Account.

39. CORPORATE GOVERNANCE:

The Company has complied with the corporate governance requirements as stipulated under the SEBI (LODR) Regulations. A separate report on corporate governance is attached as Annexure-IV to this report.

Further, a certificate from M/s M M Chawla & Associates, Company Secretary in Practice (FCS 67, CP 716) confirming the compliance of conditions of corporate governance is attached as Annexure-V to this report.

40. MANAGEMENT DISCUSSION & ANALYSIS REPORT:

As per Regulation 34(2)(e) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company was required to prepare/attach a Management Discussion and Analysis Report as a part of this Board's Report or addition thereto and the same is attached as Annexure-VI to this Report.

41. INTER - SE RELATIONSHIP OF DIRECTORS:

S. Name & DIN of Director

No.

Relation with Directors

1 Mr. Jaspal Singh (DIN: 01406945)

Father of Mr. Harman Singh (DIN: 01406962), Director & Chief Financial Officer and Mrs. Jasneet Kaur (DIN: 06995139), Director

2 Mr. Harman Singh (DIN: 01406962)

Son of Mr. Jaspal Singh (DIN: 01406945) Chairman and Managing Director and Brother of Mrs. Jasneet Kaur (DIN: 06995139), Director

3 Mrs. Jasneet Kaur (DIN: 06995139)

Daughter of Mr. Jaspal Singh (DIN: 01406945) Chairman and Managing Director and Sister of Mr. Harman Singh (DIN: 01406962), Director & Chief Financial Officer

4 Mr. Vikas Gupta (DIN: 03603519)

No Relation with Directors

5 Mr. Sandeep Singh (DIN: 03603531)

No Relation with Directors

6 Mr. Amarjot Singh (DIN: 07115513)

No Relation with Directors

42. PREVENTION OF INSIDER TRADING

The Company has adopted a Code of Conduct for Prevention of Insider Trading with a view to regulate trading in securities by the Directors and designated employees of the Company and other Connected Persons within the meaning of the concerned SEBI Regulation. The Code requires pre-clearance for dealing in the Company's shares and prohibits the purchase or sale of Company shares by the Directors and the designated employees who have access to unpublished price sensitive information in relation to the Company and during the period when the Trading Window is closed. The Board is responsible for implementation of the Code.

43. THE DETAILS OF APPLICATION MADE OR ANY PROCEEDING PENDING UNDER THE INSOLVENCY AND BANKRUPTCY CODE, 2016 DURING THE YEAR ALONGWITH THEIR STATUS AS AT THE END OF THE FINANCIAL YEAR:

No such event occur during the reporting period.

44. THE DETAILS OF DIFFERENCE BETWEEN AMOUNT OF THE VALUATION DONE AT THE TIME OF ONE TIME SETTLEMENT AND THE VALUATION DONE WHILE TAKING LOAN FROM THE BANKS OR FINANCIAL INSTITUTIONS ALONG WITH THE REASONS THEREOF:

No such event occur during the reporting period.

45. ACKNOWLEDGEMENT:

Your Directors wish to express their grateful appreciation to the continued co-operation received from the Banks, Government Authorities, Customers, Vendors and Members/Shareholders during the financial year under review. Your Directors also wish to place on record their deep sense of appreciation for the committed service of the Executives, staff and Workers of the Company.

Place: Mandideep

For and on Behalf of Board of Directors

Date: 12/08/2023

SD/-

Jaspal Singh

(DIN: 01406945) Chairman & Managing Director

   

C J Gelatine Products Ltd Company Background

Jaspal SinghJaspal Singh
Incorporation Year1983
Registered Office5 Ground Floor 237 Azad Nagar,Rahivasi Sangh Sewree
Mumbai,Maharashtra-400015
Telephone91-22-24133193,Managing Director
Fax91-22-24161368
Company SecretaryHarman Singh
AuditorS P A R K & Associates
Face Value10
Market Lot1
ListingBSE,
RegistrarAdroit Corp. Services Pvt Ltd
19/20 Jaferbhoy Ind,1st Floor Makwana Rd,Marol Naka,Mumbai - 400 059

C J Gelatine Products Ltd Company Management

Director NameDirector DesignationYear
Jaspal SinghChairman & Managing Director2023
Harman SinghExecutive Director & CFO2023
Jasneet KaurExecutive Director2023
Vikas GuptaIndependent Director2023
Sandeep SinghIndependent Director2023
Amarjot SinghIndependent Director2023
Harish PandeIndependent Director2023
S C MathurIndependent Director2023
Rajesh DivetiaIndependent Director2023
Harman SinghCompany Sec. & Compli. Officer2023

C J Gelatine Products Ltd Listing Information

C J Gelatine Products Ltd Finished Product

Product NameUnit Installed
Capacity
Production
Quantity
Sales
Quantity
Sales
Value
GelatinMT00013.18014
Dicalcium PhosphateMT0008.42411
OsseinMT0006.66022
FlyashNA0000.01797
Dicalcium PhosphateKg0000
GelatinKg0000
GSTNA0000
Sales taxNA0000
Export SalesNA0000
CommissionNA0000
Sales ReturnsKg0000
OsseinKg0000

Contact us Contact us